Literature DB >> 6522139

The effect of calcium antagonists on hypoxic pulmonary hypertension in the piglet.

P J Dickstein, O Trindade, R N Goldberg, E Bancalari.   

Abstract

Cardiovascular responses to the calcium antagonists verapamil and nifedipine were evaluated in a piglet model of hypoxic pulmonary hypertension. All animals were mechanically ventilated and paralyzed. Cardiac output (CO), pulmonary artery (Ppa) and aortic blood pressure (AoP), pulmonary wedge pressure, right atrial pressure (Pra), and arterial blood gases were measured prior to and after pulmonary hypertension was induced by hypoxia and after administration of calcium-blocking agents. Results were compared to a control group of piglets subjected to a similar period of hypoxia. Verapamil infusion (0.15 mg/kg) resulted in a rapid decrease in Ppa, AoP and pulmonary vascular resistance (p less than 0.05) which returned to baseline values by 15 min. Nifedipine (100 micrograms/kg) resulted in a decrease in Ppa at 1 min (p less than 0.05) which remained significantly lower than controls throughout the study period. AoP declined precipitously during the same time period (p less than 0.01). No significant change in Ppa was noted when nifedipine was administered at a dose of 10 micrograms/kg. For the most part, these drugs have a transient vasodilatory action on pulmonary as well as systemic circulation in this animal model; however, they might in higher doses be associated with significant systemic hypotension. For this reason, the use of these drugs in the treatment of hypoxic pulmonary hypertension in the neonate should be approached with caution.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6522139     DOI: 10.1203/00006450-198412000-00007

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  4 in total

1.  Upregulation of vascular calcium channels in neonatal piglets with hypoxia-induced pulmonary hypertension.

Authors:  Dinesh K Hirenallur-S; Steven T Haworth; Jeaninne T Leming; James Chang; Guillermo Hernandez; John B Gordon; Nancy J Rusch
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-09-05       Impact factor: 5.464

Review 2.  Treatment of persistent pulmonary hypertension of the newborn: update.

Authors:  Y K Abu-Osba
Journal:  Arch Dis Child       Date:  1991-01       Impact factor: 3.791

3.  Treatment of severe persistent pulmonary hypertension of the newborn with magnesium sulphate.

Authors:  Y K Abu-Osba; O Galal; K Manasra; A Rejjal
Journal:  Arch Dis Child       Date:  1992-01       Impact factor: 3.791

4.  Effect of increasing doses of magnesium in experimental pulmonary hypertension after acute pulmonary embolism.

Authors:  Nikolaus A Haas; Jan Kemke; Ingram Schulze-Neick; Peter E Lange
Journal:  Intensive Care Med       Date:  2004-09-09       Impact factor: 17.440

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.